Remote monitoring of cardiac implantable electronic devices (CIED)

Trends in Cardiovascular Medicine

Volumn 26, Issue 6, 2016, Pages 568-577

  Zeitler, Emily P ^a   Piccini, Jonathan P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac implantable electronic device; Cardiac resynchronization therapy; Implantable cardioverter defibrillator; Pacemaker; Remote monitoring

Indexed keywords

ATRIAL FIBRILLATION; CARDIAC IMPLANT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; ELECTRONIC DEVICE; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS (TOPIC); PACEMAKER; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE SENSING; REVIEW; ADVERSE EFFECTS; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; DEVICES; HEART DISEASES; HEART PACING; MORTALITY; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS COMPLICATION; PROSTHESIS DESIGN; RISK FACTOR; SIGNAL PROCESSING; STANDARDS; TELEMETRY; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART DISEASES; HUMANS; PACEMAKER, ARTIFICIAL; PATIENT PARTICIPATION; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REMOTE SENSING TECHNOLOGY; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TELEMETRY; TREATMENT OUTCOME;

EID: 84964575872     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2016.03.012     Document Type: Review

References (51)

1. [1] Zhan, C., Baine, W.B., Sedrakyan, A., Steiner, C., Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 23:Suppl. 1 (2008), 13–19.
2. [2] Mond, H.G., Proclemer, A., The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmiaʼs project. Pacing Clin Electrophysiol 34 (2011), 1013–1027.
3. [3] de Ruvo, E., Sciarra, L., Martino, A.M., Rebecchi, M., Iulianella, R.V., Sebastiani, F., et al. A prospective comparison of remote monitoring systems in implantable cardiac defibrillators: potential effects of frequency of transmissions. J Interv Card Electrophysiol 45 (2015), 81–90.
4. [4] Morichelli, L., Porfili, A., Quarta, L., Sassi, A., Ricci, R.P., Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up. J Interv Card Electrophysiol 41 (2014), 203–209.
5. [5] Petersen, H.H., Larsen, M.C., Nielsen, O.W., Kensing, F., Svendsen, J.H., Patient satisfaction and suggestions for improvement of remote ICD monitoring. J Interv Card Electrophysiol 34 (2012), 317–324.
6. [6] Ricci, R.P., Morichelli, L., Quarta, L., Sassi, A., Porfili, A., Laudadio, M.T., et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 12 (2010), 674–679.
7. [7] Schoenfeld, M.H., Compton, S.J., Mead, R.H., Weiss, D.N., Sherfesee, L., Englund, J., et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 27:6 Pt 1 (2004), 757–763.
8. [8] Marzegalli, M., Lunati, M., Landolina, M., Perego, G.B., Ricci, R.P., Guenzati, G., et al. Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation—ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol 31 (2008), 1259–1264.
9. [9] Hindricks, G., Elsner, C., Piorkowski, C., Taborsky, M., Geller, J.C., Schumacher, B., et al. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J 35 (2014), 98–105.
10. [10] Ren, X., Apostolakos, C., Vo, T.H., Shaw, R.E., Shields, K., Banki, N.M., et al. Remote monitoring of implantable pacemakers: in-office setup significantly improves successful data transmission. Clin Cardiol 36 (2013), 634–637.
11. [11] Rosenfeld, L.E., Patel, A.S., Ajmani, V.B., Holbrook, R.W., Brand, T.A., Compliance with remote monitoring of ICDS/CRTDS in a real-world population. Pacing Clin Electrophysiol 37 (2014), 820–827.
12. [12] Slotwiner, D., Varma, N., Akar, J.G., Annas, G., Beardsall, M., Fogel, R.I., et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm 12 (2015), e69–e100.
13. [13] Akar, J.G., Bao, H., Jones, P., Wang, Y., Chaudhry, S.I., Varosy, P., et al. Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study. Circulation 128 (2013), 2372–2383.
14. [14] Mittal, S., Movsowitz, C., Varma, N., The modern EP practice: EHR and remote monitoring. Cardiol Clin 32 (2014), 239–252.
15. [15] Ricci, R.P., Morichelli, L., DʼOnofrio, A., Calo, L., Vaccari, D., Zanotto, G., et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry. Europace 15 (2013), 970–977.
16. [16] Dubner, S., Auricchio, A., Steinberg, J.S., Vardas, P., Stone, P., Brugada, J., et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 14 (2012), 278–293.
17. [17] Slotwiner, D., Wilkoff, B., Cost efficiency and reimbursement of remote monitoring: a US perspective. Europace 15:Suppl. 1 (2013), i54–i58.
18. [18] Mabo, P., Victor, F., Bazin, P., Ahres, S., Babuty, D., Da Costa, A., et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J 33 (2012), 1105–1111.
19. [19] Hindricks, G., Taborsky, M., Glikson, M., Heinrich, U., Schumacher, B., Katz, A., et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384 (2014), 583–590.
20. [20] Parthiban, N., Esterman, A., Mahajan, R., Twomey, D.J., Pathak, R.K., Lau, D.H., et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol 65 (2015), 2591–2600.
21. [21] Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.S., et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 34 (2013), 605–614.
22. [22] Varma, N., Epstein, A.E., Irimpen, A., Schweikert, R., Love, C., TRUST Investigators, Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 122 (2010), 325–332.
23. [23] Al-Khatib, S.M., Piccini, J.P., Knight, D., Stewart, M., Clapp-Channing, N., Sanders, G.D., Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol 21 (2010), 545–550.
24. [24] Boriani, G., Da Costa, A., Ricci, R.P., Quesada, A., Favale, S., Iacopino, S., et al. The Monitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res, 15, 2013, e167.
25. [25] Crossley, G.H., Boyle, A., Vitense, H., Chang, Y., Mead, R.H., CONNECT Investigators, The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57 (2011), 1181–1189.
26. [26] Landolina, M., Perego, G.B., Lunati, M., Curnis, A., Guenzati, G., Vicentini, A., et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125 (2012), 2985–2992.
27. [27] Saxon, L.A., Hayes, D.L., Gilliam, F.R., Heidenreich, P.A., Day, J., Seth, M., et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122 (2010), 2359–2367.
28. [28] Varma, N., Piccini, J.P., Snell, J., Fischer, A., Dalal, N., Mittal, S., The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. J Am Coll Cardiol 65 (2015), 2601–2610.
29. [29] Cronin, E.M., Ching, E.A., Varma, N., Martin, D.O., Wilkoff, B.L., Lindsay, B.D., Remote monitoring of cardiovascular devices: a time and activity analysis. Heart Rhythm 9 (2012), 1947–1951.
30. [30] Perl, S., Stiegler, P., Rotman, B., Prenner, G., Lercher, P., Anelli-Monti, M., et al. Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial). Int J Cardiol 169 (2013), 402–407.
31. [31] Hauser, R.G., Kallinen, L.M., Almquist, A.K., Gornick, C.C., Katsiyiannis, W.T., Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 4 (2007), 892–896.
32. [32] Catanzariti, D., Lunati, M., Landolina, M., Zanotto, G., Lonardi, G., Iacopino, S., et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol 32 (2009), 363–370.
33. [33] van Veldhuisen, D.J., Braunschweig, F., Conraads, V., Ford, I., Cowie, M.R., Jondeau, G., et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124 (2011), 1719–1726.
34. [34] Whellan, D.J., Ousdigian, K.T., Al-Khatib, S.M., Pu, W., Sarkar, S., Porter, C.B., et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 55 (2010), 1803–1810.
35. [35] Crossley, G.H., Chen, J., Choucair, W., Cohen, T.J., Gohn, D.C., Johnson, W.B., et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol 54 (2009), 2012–2019.
36. [36] Ricci, R.P., Morichelli, L., Santini, M., Remote control of implanted devices through home monitoring technology improves detection and clinical management of atrial fibrillation. Europace 11 (2009), 54–61.
37. [37] Sanna, T., Diener, H.C., Passman, R.S., Di Lazzaro, V., Bernstein, R.A., Morillo, C.A., et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370 (2014), 2478–2486.
38. [38] Healey, J.S., Connolly, S.J., Gold, M.R., Israel, C.W., Van Gelder, I.C., Capucci, A., et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366 (2012), 120–129.
39. [39] Guedon-Moreau, L., Lacroix, D., Sadoul, N., Clementy, J., Kouakam, C., Hermida, J.S., et al. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace 16 (2014), 1181–1188.
40. [40] Zanaboni, P., Landolina, M., Marzegalli, M., Lunati, M., Perego, G.B., Guenzati, G., et al. Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial. J Med Internet Res, 15, 2013, e106.
41. [41] Klersy, C., De Silvestri, A., Gabutti, G., Raisaro, A., Curti, M., Regoli, F., et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail 13 (2011), 450–459.
42. [42] Heidbuchel, H., Hindricks, G., Broadhurst, P., Van Erven, L., Fernandez-Lozano, I., Rivero-Ayerza, M., et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J 36 (2015), 158–169.
43. [43] Fauchier, L., Sadoul, N., Kouakam, C., Briand, F., Chauvin, M., Babuty, D., et al. Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 28:Suppl. 1 (2005), S255–S259.
44. [44] Calo, L., Gargaro, A., De Ruvo, E., Palozzi, G., Sciarra, L., Rebecchi, M., et al. Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study. J Interv Card Electrophysiol 37 (2013), 69–78.
45. [45] Burri, H., Sticherling, C., Wright, D., Makino, K., Smala, A., Tilden, D., Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace 15 (2013), 1601–1608.
46. [46] Raatikainen, M.J., Uusimaa, P., van Ginneken, M.M., Janssen, J.P., Linnaluoto, M., Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace 10 (2008), 1145–1151.
47. [47] Zabel, M., Muller-Riemenschneider, F., Geller, J.C., Brachmann, J., Kuhlkamp, V., Dissmann, R., et al. Rationale and design of the MONITOR-ICD study: a randomized comparison of economic and clinical effects of automatic remote monitoring versus control in patients with implantable cardioverter defibrillators. Am Heart J 168 (2014), 430–437.
48. [48] Ricci, R.P., DʼOnofrio, A., Padeletti, L., Sagone, A., Vicentini, A., Vincenti, A., et al. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace 14 (2012), 1661–1665.
49. [49] Yee, R., Verma, A., Beardsall, M., Fraser, J., Philippon, F., Exner, D.V., Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position statement on the use of remote monitoring for cardiovascular implantable electronic device follow-up. Can J Cardiol 29 (2013), 644–651.
50. [50] de Cock, C.C., Elders, J., van Hemel, N.M., van den Broek, K., van Erven, L., de Mol, B., et al. Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: an expert consensus report of the Netherlands Society of Cardiology. Neth Heart J 20 (2012), 53–65.
51. [51] Wilkoff, B.L., Auricchio, A., Brugada, J., Cowie, M., Ellenbogen, K.A., Gillis, A.M., et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency, and ethical considerations. Heart Rhythm 5 (2008), 907–925.